MYC and exocrine pancreatic carcinoma: Accumulating evidence suggests that curcumin is a phenolic compound extracted from turmeric that can overcome dFdC resistance in pancreatic carcinoma by inhibiting the PRC2-PVT1-c-Myc axis (Yoshida et al., 2017).